====== BVD-523 15μM R02 exp67 ======
==== Mechanism of Action ====
Inhibits ERK1/2, ATP-competitive
* **Class / Subclass 1:** Signal Transduction / Kinase Inhibitor
==== Technical Notes ====
* **PubChem Name:** %%Ulixertinib%%
* **Synonyms:** BVD-523; VRT752271
* **CAS #:** 869886-67-9
* **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/11719003|11719003]]
* **IUPAC:** %%N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-4-[5-chloro-2-(propan-2-ylamino)pyridin-4-yl]-1H-pyrrole-2-carboxamide%%
* **INCHI Name:** InChI=1S/C21H22Cl2N4O2/c1-12(2)26-20-8-16(17(23)10-25-20)14-7-18(24-9-14)21(29)27-19(11-28)13-4-3-5-15(22)6-13/h3-10,12,19,24,28H,11H2,1-2H3,(H,25,26)(H,27,29)/t19-/m1/s1
* **INCHI Key:** KSERXGMCDHOLSS-LJQANCHMSA-N
* **Molecular Weight:** 433.3
* **Canonical SMILES:** CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl
* **Isomeric SMILES:** CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)Cl
* **Molecular Formula:** C21H22Cl2N4O2
{{:chemogenomics:structures:chem-0043.svg?nolink}}
* **Supplier Name:** Selleck Chemicals
* **Catalog #:** S7854
* **Lot #:** S785401
* **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C21H22Cl2N4O2 433.11926; found 433.1203
* **Platform ID:** BVD-523
* **Min:** -21.4275; **Max:** 66.0260
{{:chemogenomics:dose_response:dr_34.png?nolink&500 |}}
\\
\\
\\
\\
|< 300px 100px 200px >|
^ IC ^ Concentration (µM) ^
| IC10 |N/A |
| IC20 |17.1654 |
| IC30 |17.9440 |
| IC40 |18.6085 |
| IC50 |19.2400 |
| IC60 |N/A |
| IC70 |N/A |
| IC80 |N/A |
| IC90 |N/A |
\\
==== Screen Summary ====
* **Round**: 02
* **Dose**: 15µM
* **Days of incubation**: 8
* **Doublings**: 1.0
* **Numbers of reads**: 12552010
==== Screen Results ====
^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^
|33/19|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/BVD-523_15uM_Round-2_exp67.txt|Scores]]||||||
{{:chemogenomics:cranks_plots:exp67.png?nolink}}
^Gene^CRANKS Score^FDR^
|[[:human_genes:P:PCYT1A|PCYT1A]]|-3.87|<0.01|
|[[:human_genes:Y:YPEL5|YPEL5]]|-3.79|<0.01|
|[[:human_genes:F:FLVCR1|FLVCR1]]|-3.58|<0.01|
|[[:human_genes:T:TSC2|TSC2]]|-3.57|<0.01|
|[[:human_genes:C:CEPT1|CEPT1]]|-3.34|<0.01|
|[[:human_genes:O:OTUB1|OTUB1]]|-3.23|<0.01|
|[[:human_genes:P:PSMA3|PSMA3]]|-3.12|0.01|
|[[:human_genes:T:TCF3|TCF3]]|-2.97|0.01|
|[[:human_genes:I:IKZF2|IKZF2]]|-2.94|<0.01|
|[[:human_genes:W:WDR26|WDR26]]|-2.92|0.01|
|[[:human_genes:N:NPRL3|NPRL3]]|-2.92|0.01|
|[[:human_genes:P:PCGF1|PCGF1]]|-2.88|<0.01|
|[[:human_genes:U:UBE2E1|UBE2E1]]|-2.86|<0.01|
|[[:human_genes:P:PDS5B|PDS5B]]|-2.79|<0.01|
|[[:human_genes:S:SLC5A3|SLC5A3]]|-2.75|<0.01|
|[[:human_genes:G:GPR107|GPR107]]|-2.73|<0.01|
|[[:human_genes:F:FAM122A|FAM122A]]|-2.68|<0.01|
|[[:human_genes:S:SOX4|SOX4]]|-2.65|0.04|
|[[:human_genes:M:MUL1|MUL1]]|-2.62|0.02|
|[[:human_genes:D:DEPDC5|DEPDC5]]|-2.62|0.01|
|[[:human_genes:R:RUVBL2|RUVBL2]]|-2.59|0.38|
|[[:human_genes:S:SREK1|SREK1]]|-2.54|0.05|
|[[:human_genes:T:TCF4|TCF4]]|-2.54|0.02|
|[[:human_genes:Y:YIPF5|YIPF5]]|-2.46|0.02|
|[[:human_genes:C:CNOT8|CNOT8]]|-2.45|0.02|
|[[:human_genes:Z:ZFAND5|ZFAND5]]|-2.43|0.04|
|[[:human_genes:T:TSSC1|TSSC1]]|-2.38|0.04|
|[[:human_genes:U:UNC50|UNC50]]|-2.35|0.04|
|[[:human_genes:E:ELMSAN1|ELMSAN1]]|-2.33|0.04|
|[[:human_genes:F:FIS1|FIS1]]|-2.32|0.04|
|[[:human_genes:S:SPATA17|SPATA17]]|2.26|0.07|
|[[:human_genes:B:BRCC3|BRCC3]]|2.28|0.09|
|[[:human_genes:Z:ZNF608|ZNF608]]|2.28|0.06|
|[[:human_genes:K:KMT2D|KMT2D]]|2.29|0.06|
|[[:human_genes:Z:ZRSR2|ZRSR2]]|2.32|0.08|
|[[:human_genes:P:PDCD5|PDCD5]]|2.33|0.05|
|[[:human_genes:F:FKBPL|FKBPL]]|2.37|0.04|
|[[:human_genes:M:MRAS|MRAS]]|2.37|0.07|
|[[:human_genes:N:NRG2|NRG2]]|2.37|0.04|
|[[:human_genes:I:ID4|ID4]]|2.38|0.04|
|[[:human_genes:U:UBR5|UBR5]]|2.39|0.09|
|[[:human_genes:I:IMPDH2|IMPDH2]]|2.43|0.06|
|[[:human_genes:P:PKNOX1|PKNOX1]]|2.44|0.09|
|[[:human_genes:D:DDX42|DDX42]]|2.47|0.03|
|[[:human_genes:Y:YARS|YARS]]|2.53|0.10|
|[[:human_genes:T:TRIP12|TRIP12]]|2.56|0.02|
|[[:human_genes:K:KANSL1|KANSL1]]|2.76|0.03|
|[[:human_genes:S:SCAF8|SCAF8]]|2.79|<0.01|
|[[:human_genes:T:TRIM28|TRIM28]]|2.95|<0.01|
|[[:human_genes:C:CSNK2A1|CSNK2A1]]|2.99|<0.01|
|[[:human_genes:P:PPP2R2A|PPP2R2A]]|2.99|<0.01|
|[[:human_genes:N:NSD1|NSD1]]|3.18|<0.01|
|[[:human_genes:F:FBXO11|FBXO11]]|3.20|<0.01|
|[[:human_genes:C:CSNK2B|CSNK2B]]|3.20|<0.01|
|[[:human_genes:B:BAK1|BAK1]]|3.35|<0.01|
|[[:human_genes:P:PPME1|PPME1]]|3.60|<0.01|
|[[:human_genes:T:TFAP4|TFAP4]]|3.74|<0.01|
|[[:human_genes:P:PPP6C|PPP6C]]|4.10|<0.01|
|[[:human_genes:T:TIPRL|TIPRL]]|4.51|<0.01|
|[[:human_genes:L:LCMT1|LCMT1]]|5.45|<0.01|
^Screen^Correlation^Plot^
|[[:results:exp217|Mdivi-1 15μM R05 exp217]]|0.118||
|[[:results:exp80|RO-3307 4.7μM R02 exp80]]|0.099||
|[[:results:exp59|UMK57 1μM R01 exp59]]|0.098||
|[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|0.093||
|[[:results:exp502|Milciclib 2μM R08 exp502]]|0.079||
|[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|0.078||
|[[:results:exp269|Bisphenol A 100μM R06 exp269]]|0.075||
|[[:results:exp466|Cannabidiol 20μM R08 exp466]]|0.072||
|[[:results:exp435|JQ1 0.8μM R08 exp435]]|0.071||
|[[:results:exp90|WYE-354 6μM R02 exp90]]|0.07||
|[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|0.07||
|[[:results:exp106|UM131593 0.2μM R03 exp106]]|0.066||
|[[:results:exp85|UM0129480 7μM R02 exp85]]|0.066||
|[[:results:exp515|PU-H71 1μM R08 exp515]]|0.065||
|[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|0.064||
|[[:results:exp517|Quercetin 20μM R08 exp517]]|0.063||
|[[:results:exp343|Centrinone 0.5μM R07 exp343]]|0.062||
|[[:results:exp224|CB-839 10μM R05 exp224]]|0.061||
|[[:results:exp468|CB-5083 0.4μM R08 exp468]]|0.058||
|[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|0.058||
|[[:results:exp499|LY2090314 0.003μM R08 exp499]]|0.058||
|[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|0.057||
|[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|0.057||
|[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|0.057||
|[[:results:exp510|Nicotine 3000μM R08 exp510]]|0.054||
|[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|0.054||
|[[:results:exp359|FK-506 30μM R07 exp359]]|0.053||
|[[:results:exp78|Pterostilbene 16μM R02 exp78]]|0.053||
|[[:results:exp442|Ibrutinib 10μM R08 exp442]]|0.051||
|[[:results:exp460|BML-284 0.09μM R08 exp460]]|0.107||
|[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|0.084||
|[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|0.054||
|[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|0.051||
{{:chemogenomics:comparison_plots:exp217_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp67_vs_exp80.png?nolink |}}
{{:chemogenomics:comparison_plots:exp59_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp445_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp502_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp500_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp269_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp466_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp435_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp67_vs_exp90.png?nolink |}}
{{:chemogenomics:comparison_plots:exp357_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp106_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp67_vs_exp85.png?nolink |}}
{{:chemogenomics:comparison_plots:exp515_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp226_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp517_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp343_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp224_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp468_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp499_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp282_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp294_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp356_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp510_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp28_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp359_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp67_vs_exp78.png?nolink |}}
{{:chemogenomics:comparison_plots:exp442_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp460_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp312_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp440_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp311_vs_exp67.png?nolink |}}
No GO term hits below threshold. (FDR <0.05)
^GO Term^Fold Change^Genes^
|disruption by symbiont of host cellular component|552.80|CSNK2B,CSNK2A1|
|DNA repair-dependent chromatin remodeling|97.55|TRIP12,UBR5,BRCC3|